Twelfth EDCTP Forum

15–20 Jun 2025 | Kigali, Rwanda

Register
Register
Register

Monday, 16 June 2025 | 10:30 - 12:30

1.1 Parallel session: Mobilising the research response to Mpox

Location:MH1Track:Parallel Session

Presentations:

OA-693 - Strengthening epidemiological, genomic, and community surveillance of mpox virus (MPXV) at the Congo River Border for DRC and RoC

Tania Bishola, University of Kinshasa, Democratic Republic of the Congo

OA-169 - Genomic monitoring and tracking of mpox virus clade Ib after the introduction into Burundi at the end of July until mid-September 2024

Néhémie Nzoyikorera, National Public Health Institute of Burundi, Burundi

OA-747 - Transmission dynamics, clinical outcomes, and pregnancy implications of clade Ib Mpox in South Kivu, Democratic Republic of Congo

Pacifique Ndishimye, Stansile, Canada

OA-306 - Acceptability and perceptions of mpox vaccination and vaccine trials in pregnant women and infants during the PregInPoxVac trial in Boende, Democratic Republic of Congo – ACCEPTED

Marthe Le Prevost, Fondazione Penta ETS, Italy

OA-273 - Strengthening mpox vaccine trials through community engagement: findings from participatory workshops with women, healthcare professionals, and community leaders in Boende, DRC

Marthe Le Prevost, Fondazione Penta ETS, Italy

OA-258 - Closing the evidence gap: advancing maternal mpox vaccination in the DRC – a phase 3 trial on MVA-BN - ACCEPTED

Paulina Morales Ruiz, Global Health Institute, Belgium